Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs by OSTEBA in Spain in late October 2023

25 Oct 2023

In late October 2023, the Basque Office for Health Technology Assessment (OSTEBA) is working on several HTAs, including the evaluations in the cardiovascular, diagnostic imaging, e-health, ENT, ICU/OR, nephrology and urology, IVD, neurovascular, obstetrics and gynecology, surgical procedures, and some other fields. Some examples can be found below:

  • Telemonitoring and computerized management of patients on home dialysis and rehabilitation activities;
  • Cardiovascular monitoring system that uses photoplethysmography;
  • Intrasaccular device for endovascular treatment of brain aneurysms;
  • Clinical efficacy and cost-effectiveness of incorporating artificial intelligence into the breast cancer screening program;
  • Use and utility of adaptive radiotherapy in cancer patients;
  • Active piezoelectric bone conduction hearing implant;
  • High-intensity focused ultrasound - in essential tremor (update);
  • Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of pediatric patients with peritoneal carcinomatosis;
  • Use of self-taking tests for the determination of Human Papillomavirus in the cervical cancer screening program.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.